In vivo measurement of extravasation of silver nanoparticles into liver extracellular space by push-pull-based continuous monitoring system

Toxicology Letters

Volumn 227, Issue 2, 2014, Pages 84-90

  Su, Cheng Kuan ^a   Hung, Ching Wen ^a   Sun, Yuh Chang ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Extravasation; Inductively coupled plasma mass spectrometry; Nanotoxicology; Push pull perfusion; Silver nanoparticles

Indexed keywords

SILVER NANOPARTICLE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); EXTRACELLULAR SPACE; EXTRAVASATION; IN VIVO STUDY; LIMIT OF DETECTION; LIVER CLEARANCE; LIVER PERFUSION; MALE; MASS SPECTROMETRY; MONITORING; NONHUMAN; ONLINE MONITORING; PRIORITY JOURNAL; PUSH PULL BASED CONTINUOUS MONITORING SYSTEM; RAT; RETICULOENDOTHELIAL SYSTEM; SOLID PHASE EXTRACTION; TRANSPORT KINETICS;

EXTRAVASATION; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; NANOTOXICOLOGY; PUSH-PULL PERFUSION; SILVER NANOPARTICLES;

ANIMALS; DRUG STABILITY; EXTRACELLULAR SPACE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; LIVER; MALE; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; MONITORING, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SILVER; SOLID PHASE EXTRACTION;

EID: 84899107253     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.03.014     Document Type: Article

References (25)

1. Benn T.M., Westeroff P. Nanoparticle silver released into water from commercially available sock fabrics. Environ. Sci. Technol. 2008, 42:4133-4139.
2. Casals E., Pfaller T., Duschl A., Oostingh G.J., Puntes V. Time evolution of the nanoparticle protein corona. ACS Nano 2010, 4:3623-3632.
3. Chauhan V.P., Popovic Z., Chen O., Cui J., Fukumura D., Bawendi M.G., Jain R.K. Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. Angew. Chem. Int. Ed. 2011, 50:11417-11420.
4. Cheng S., Li F., Souris J.S., Yang C., Tseng F., Lee H., Chen C., Dong C., Lo L. Visualizing dynamics of sub-hepatic distribution of nanoparticles using intravital multiphoton fluorescence microscopy. ACS Nano 2012, 6:4122-4131.
5. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty I.B., Bawendi M.G., Frangioni1 J.V. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25:1165-1170.
6. Chrastina A., Schnitzer J.E. Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int. J. Nanomed. 2010, 5:653-659.
7. Clift M.J.D., Bhattacharjeea S., Browna D.M., Stonea V. The effects of serum on the toxicity of manufactured nanoparticles. Toxicol. Lett. 2010, 198:358-365.
8. Fischer C.H, Siebrands T. Analysis of colloids VIII. Concentration- and memory effects in size exclusion chromatography of colloidal inorganic nanometer-particles. J. Chromatogr. A 1995, 707:189-197.
9. Jian J., Oberdörster G., Biswas P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J. Nanopart. Res. 2009, 11:77-89.
10. Kittler S., Greulich C., Gebauer J.S., Diendorf J., Treuel L., Ruiz L., Gonzalez-Calbet J.M., Vallet-Regi M., Zellner R., Koller M., Epple M. The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles. J. Mater. Chem. 2010, 20:512-518.
11. Kottegoda S., Shaik I., Shippy S.A. Demonstration of low flow push-pull perfusion. J. Neurosci. Methods 2002, 121:93-101.
12. Kowalczyk B., Lagzi I., Grzybowski B.A. Nanoseparations: strategies for size and/or shape-selective purification of nanoparticles. Curr. Opin. Colloid Interface Sci 2011, 16:135-148.
13. Levitt D.G. The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption. BMC Clin. Pharmacol. 2003, 3:3.
14. Li M., Al-Jamal K.T., Kostarelos K., Reineke J. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano 2010, 4:6303-6317.
15. Liu W., Zhou Q.F., Liu J.Y., Fu J.J., Liu S.J., Jiang G.B. Environmental and biological influences on the stability of silver nanoparticles. Chin. Sci. Bull. 2012, 56:2009-2015.
16. Mišlanová C., Hutta M. Role of biological matrices during the analysis of chiral drugs by liquid chromatography. J. Chromatogr. B. 2003, 797:91-109.
17. Muller N.C., Nowack B. Exposure modeling of engineered nanoparticles in the environment. Environ. Sci. Technol. 2008, 42:4447-4453.
18. Park E., Bae E., Yi J., Kim Y., Choi K., Lee S.H., Yoon J., Lee B.C., Park K. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ. Toxicol. Pharmacol. 2010, 30:162-168.
19. PEN (Project on Emerging Nanotechnologies) An inventory of nanotechnology-based consumer products currently on the market 2013, http://www.nanotechproject.org/inventories/consumer/analysis_draft/.
20. Popovic Z., Liu W., Chauhan V.P., Lee J., Wong C., Greytak A.B., Insin N., Nocera D.G., Fukumura D., Jain R.K., Bawendi M.G. A nanoparticle size series for in vivo fluorescence imaging. Angew. Chem. Int. Ed. 2010, 49:8649-8652.
21. Renwick L.C., Donaldson K., Clouter A. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol. Appl. Pharmacol. 2001, 172:119-127.
22. Su C.K., Huang C.W., Yang C.S., Wang Y.J., Sun Y.C. In vivo monitoring of quantum dots in the extracellular space using push-pull perfusion sampling, online in-tube solid phase extraction, and inductively coupled plasma mass spectrometry. Anal. Chem. 2010, 82:7096-7102.
23. Torchilin V.P. Nanoparticulates as Drug Carriers 2006, Imperial College Press, London, MA, USA.
24. Wang B., He X., Zhang Z., Zhao Y. Metabolism of nanomaterials in vivo: blood circulation and organ clearance. Acc. Chem. Res. 2013, 46:761-769.
25. Weiss M., Reekers M., Vuyk J., Boer F. Circulatory model of vascular and interstitial distribution kinetics of rocuronium: a population analysis in patients. J. Pharmacokinet. Pharmacodyn. 2011, 38:165-178.